Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences

Author's Avatar
Nov 08, 2022

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences: